Interindividual variability and its impact on the effectiveness of Janus kinase inhibitors in rheumatoid arthritis treatment

IntroductionAchieving the primary treat-to-target (T2T) goal in rheumatoid arthritis (RA) remains challenging for many patients, reflecting limitations in the effectiveness of existing treatments. Our study examines factors influencing Janus kinase (JAK) inhibitor effectiveness by analyzing interind...

Descripció completa

Dades bibliogràfiques

Autors principals:	Cristina Martinez-Molina, Silvia Vidal, Cesar Diaz-Torne, Hye S. Park, Hèctor Corominas
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2025-03-01
Col·lecció:	Frontiers in Medicine
Matèries:	Janus kinase inhibitor tofacitinib baricitinib upadacitinib filgotinib treatment effectiveness
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1512501/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!